Get the Stockscreener App
2.14
10.88%
0.21
Calidi Biotherapeutics Inc Stock (CLDI) Latest News
Calidi Biotherapeutics announces pricing of $7.5M public offering of common stock - MSN
Calidi Biotherapeutics Inc (CLDI-A) QuotePress Release - The Globe and Mail
If You Don’t Buy Calidi Biotherapeutics Inc (AMEX: CLDI) Now, You’ll Kick Yourself Later - Stocks Register
Calidi Biotherapeutics Reveals Promising Virotherapy Data - TipRanks
Calidi Biotherapeutics Presents Data Supporting RTNova Systemic Technology to Target Metastatic Lung Cancer - EIN News
Calidi presents data on RTNova systemic technology in metastatic lung cancer - TipRanks
Calidi Bio's RTNova Shows Promise in Metastatic Lung Cancer Treatment Breakthrough | CLDI Stock News - StockTitan
Calidi Biotherapeutics Announces Closing of $7.5 Million Public Offering of Common Stock - The Manila Times
Calidi Biotherapeutics Raises $7.5M Through Public Offering of 4.4M Shares | CLDI Stock News - StockTitan
Pre-market Movers: GANX, TFFP, AKYA, CLDI... - RTTNews
SEC Form 424B5 filed by Calidi Biotherapeutics Inc. - Quantisnow
Calidi Biotherapeutics (NYSE American: CLDI) Announces Public Offering - Barchart
Calidi prices 4.4M shares at $1.69 in public offering - TipRanks
Calidi Biotherapeutics Announces Pricing of $7.5 Million Public Offering of Common Stock - The Manila Times
Calidi Biotherapeutics Raises $7.5M in Public Offering for Clinical Trials | CLDI Stock News - StockTitan
Calidi announces common stock offering, no amount given - TipRanks
Calidi Biotherapeutics Surges on 3Q Report, Retreats on Stock-Offer News - MarketWatch
Calidi Biotherapeutics plans stock offering - Investing.com India
Calidi Biotherapeutics plans stock offering By Investing.com - Investing.com Canada
Calidi Biotherapeutics Announces Proposed Public Offering - The Manila Times
Calidi Biotherapeutics Launches Public Stock Offering to Fund Corporate Growth | CLDI Stock News - StockTitan
Calidi Biotherapeutics Advances with FDA Clearance and Funding - TipRanks
Calidi Biotherapeutics Reports Third Quarter 2024 Operating and Financial Results - The Manila Times
Calidi Bio Gets FDA Nod for Brain Cancer Drug Trial Amid $5.1M Q3 Loss | CLDI Stock | CLDI Stock News - StockTitan
Calidi Biotherapeutics’ $2.1 Million Shares Offering - Global Legal Chronicle
Contrasting BioCryst Pharmaceuticals (NASDAQ:BCRX) & Calidi Biotherapeutics (NYSE:CLDI) - Defense World
CLDICalidi Biotherapeutics, Inc. Latest Stock News & Market Updates - StockTitan
Calidi Biotherapeutics’ (NYSE American: CLDI) Groundbreaking Cancer Treatment on RedChip’s Bloomberg TV Program - Barchart
Nexalin Technology and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - AccessWire
Calidi to present data supporting RTNova at upcoming conferences - TipRanks
Calidi Biotherapeutics to Present Data Supporting RTNova at Upcoming Scientific Conferences - The Manila Times
Calidi to sell 2.05M shares at $1.00 in registered direct offering - Yahoo Finance
Calidi Biotherapeutics stock tumbles on $2M securities offering - MSN
CLDI stock touches 52-week low at $0.95 amid sharp annual decline By Investing.com - Investing.com South Africa
CLDI stock touches 52-week low at $0.95 amid sharp annual decline - Investing.com
Why Calidi Biotherapeutics (CLDI) Stock Is Down 13% - Benzinga
Calidi Biotherapeutics secures $2 million in equity financing - Investing.com
Calidi Biotherapeutics Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placement - The Manila Times
Calidi Biotherapeutics Faces Warrant Delisting by NYSE - Yahoo Finance
NYSE American to Commence Delisting Proceedings with Respect to the Warrants of Calidi Biotherapeutics, Inc. (CLDI WS) - The Manila Times
Calidi Biotherapeutics and Gorilla Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - AccessWire
Exchange Income Corp (EIF-T) QuotePress Release - The Globe and Mail
Cocoa #7 (CAU21) Quote - The Globe and Mail
Wendy Pizarro - Los Angeles Times
CLDI stock touches 52-week low at $1 amid market challenges - Investing.com Canada
Adv Micro Devices (AMD-Q) QuotePress Release - The Globe and Mail
Calidi Biotherapeutics Gains FDA Nod for Brain Cancer Trial - TipRanks
Calidi Biotherapeutics Announces FDA Clearance of the Northwestern University IND Application for CLD-101 - U.S. Politics Today
Calidi Biotherapeutics Announces FDA Clearance of the Northwestern University IND Application for CLD-101 Clinical Trial in High-Grade Glioma - The Manila Times
1.35%
0.87%
Cap:
|
Volume (24h):